ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,624.97
      -0.16%
      US Tech 100
      20,081.15
      -0.19%
      Dow Jones
      39,838.20
      0.29%
      Brent Oil
      84.66
      -0.46%
      Bitcoin
      58,219.19
      0.80%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Redhill Biopharma Ltd (RDHL)

      7. Redhill Biopharma Ltd (RDHL) News

      RDHL

      Redhill Biopharma (RDHL)

      Redhill Biopharma Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:RDHL
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      02/06/20237:00AMPR Newswire (US)RedHill Biopharma and HealthCare Royalty Agree to Extinguish All RedHill's Debt Obligations in Exchange for Movantik®NASDAQ:RDHLRedhill Biopharma Ltd
      01/26/20237:03AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      01/26/20237:00AMPR Newswire (US)RedHill Receives USPTO Notice of Allowance for a Patent Covering Phase 3-stage RHB-204 for the Treatment of NTM DiseaseNASDAQ:RDHLRedhill Biopharma Ltd
      01/13/20238:05AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RDHLRedhill Biopharma Ltd
      01/04/20239:10AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RDHLRedhill Biopharma Ltd
      01/03/20237:03AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      01/03/20237:00AMPR Newswire (US)RedHill Announces Publication of Positive Phase 2 Study Results with Once-Daily Oral RHB-107 in Non-Hospitalized COVID-19NASDAQ:RDHLRedhill Biopharma Ltd
      12/27/20227:01AMEdgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:RDHLRedhill Biopharma Ltd
      12/20/20227:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      12/12/20227:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      12/08/20229:19AMEdgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)NASDAQ:RDHLRedhill Biopharma Ltd
      12/06/20221:39PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      12/06/20221:36PMPR Newswire (US)RedHill Biopharma Closes $8.0 Million Underwritten Public OfferingNASDAQ:RDHLRedhill Biopharma Ltd
      12/06/20226:05AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:RDHLRedhill Biopharma Ltd
      12/05/20224:25PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      12/05/20227:04AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      12/02/20225:37PMDow Jones NewsADRs End Mostly Higher, H World and RedHill BioPharma Trade ActivelyNASDAQ:RDHLRedhill Biopharma Ltd
      12/02/20229:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      12/02/20229:00AMPR Newswire (US)RedHill Biopharma Prices $8.0 Million Underwritten Public OfferingNASDAQ:RDHLRedhill Biopharma Ltd
      12/02/20226:33AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:RDHLRedhill Biopharma Ltd
      12/01/20224:01PMPR Newswire (US)RedHill Biopharma Announces Proposed Public OfferingNASDAQ:RDHLRedhill Biopharma Ltd
      11/29/20228:00AMPR Newswire (US)RedHill Biopharma Announces Q3/22 Results and Operational HighlightsNASDAQ:RDHLRedhill Biopharma Ltd
      11/17/20228:33AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      11/17/20228:30AMPR Newswire (US)RedHill Biopharma Announces Positive New Data with Opaganib for Nuclear Radiation InjuryNASDAQ:RDHLRedhill Biopharma Ltd
      11/14/20227:00AMPR Newswire (US)RedHill Accelerates Opaganib's Nuclear Radiation Protection Program - Positive Data PublishedNASDAQ:RDHLRedhill Biopharma Ltd
      11/14/20227:00AMPR Newswire (Canada)RedHill Accelerates Opaganib's Nuclear Radiation Protection Program - Positive Data PublishedNASDAQ:RDHLRedhill Biopharma Ltd
      11/14/20226:12AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      11/14/20226:00AMPR Newswire (US)RedHill Biopharma Reaches Agreement in Principle with HCR to Extinguish All Debt Obligations in Exchange for Movantik®NASDAQ:RDHLRedhill Biopharma Ltd
      11/10/20224:31PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:RDHLRedhill Biopharma Ltd
       Showing the most relevant articles for your search:NASDAQ:RDHL